.
Radioisotopic assays of vitamin B12 are being increasingly introduced into haematological practice because of the considerable saving of technical time and the lesser likelihood of assay failure in comparison with microbiological assays. A serious inadequacy of many radioisotopic assays for vitamin B12 was suggested when Kolhouse et al' observed that many commercial kits used "intrinsic factor" containing large amounts of R proteins; they suggested that the binding of cobalamin analogues in serum to the R proteins lead to a loss of specificity of the assay and a failure to detect vitamin B12 deficiency in some patients. Although others have been unable to demonstrate such cobalamin analogues in serum2 3 manufacturers have nevertheless modified assay kits either by purifying intrinsic factor or by blocking R proteins thereby leaving intrinsic factor as the effective binding protein. We have assessed a commercial kit based on the latter principle, in which the contaminating R proteins are blocked by vitamin B12 analogues which lack the nucleotide of cobalamin and thus combine with R proteins but not with intrinsic factor. ugIl) .
Microbiological and radioassay of vitamin B12 was carried out in parallel on samples from 100 normal volunteers 55 of whom were women. Their age range was from 17 to 55 yr. Mean values and 95% reference ranges were derived.
Both types of vitamin B12 assay were performed in parallel on 284 consecutive patient samples on which a serum vitamin B12 assay had been requested by clinical staff; in the majority, an assay of red cell folate was carried out on a sample obtained simultaneously.
Reproducibility was studied for both microbiological and radioassay using a single large serum sample from a normal volunteer which was assayed five times in one batch and four times in another batch by both methods. Between-batch reproducibility of the radioassay for patient samples was also assessed by repeating assays on 20 consecutive samples from a single batch in another batch.
Linearity was studied for both methods by serial dilutions of a sample of normal serum, of known vitamin B12 concentration, in a pool of sera with low vitamin B12 concentrations. 
Results
Serum vitamin B12 concentrations on the 100 healthy subjects had a log-normal distribution both by microbiological assay and radioassay; logarithmic transformation was therefore used to derive means and normal (reference) ranges (Table) and to assess the correlation between the two methods. The difference between mean values for men and women was statistically significant only for the microbiological assay (p < 0 05) and was not of such a magnitude as to be of practical importance. There was a good correlation between the microbiological and radioassay results of the normal subjects (r = 0 87) and no significant difference between the mean values (p > 0 05). The 284 consecutive patient samples showed a somewhat worse correlation (r = 0 78, or r = 0-80 if grossly discrepant results from a single patient on antituberculous chemotherapy were excluded).
Reproducibility of the radioassay was better than reproducibility of the microbiological assay (coefficients of variation 7-0% and 10 7% respectively); this was attributable to greater between-batch variation with microbiological assay. Between-batch reproducibility studies for the radioassay on 20 consecutive patient samples gave a coefficient of variation of 9-9% and a correlation coefficient of 0-98. Linearity of both assay methods was excellent and correlation between the results obtained from the serial dilutions for both methods was also excellent (r = 099). During the first year of use of the radioassay 1063 patient samples were assayed. Of these, 161 samples (15%) from 127 patients gave assay results below the reference range. Seventy-one samples (6-6%) from 54 patients gave assay results of less than 100 ng/l; further assessment of these 54 patients was made. Twenty-one patients had proven, or strongly suspected vitamin B12 deficiency, four were vegetarians, and a further 20 patients had low concentrations by both microbiological and radioassay. In only nine patients did it appear that radioassay results were falsely low. Investigations of the 73 patients with serum vitamin B12 concentrations between 100 and 164 ng/l were found to have been much less detailed but as would be expected, the proportion of patients with proven B,2 deficiency was lower in this group, while the proportion of unexplained low serum B12 concentration was higher.
Discussion
We have assessed the Becton Dickinson Vitamin B,2 57Co Radioassay Kit, a competitive protein binding Bain, Broom, Woodside, Litwinczuk, Wickramasinghe radioassay. Linearity was found to be excellent, and reproducibility was satisfactory. The reference range was found to be similar to that for microbiological assay using L leichmannii. The lower serum vitamin B,2 concentrations we have observed in women (significant only for the microbiological assay) is of interest. Since serum vitamin B12 falls during pregnancy there may be a hormonal influence in nonpregnant women causing a somewhat lower concentration of serum vitamin B12 than is found in men.
It has frequently been observed that some commercial kits used in some laboratories give misleadingly normal serum vitamin B12 assay results in a significant proportion of patients with pernicious anaemia. 15 This observation has been attributed to the presence in "intrinsic factor" preparations of R proteins which bind cobalamin analogues as well as cobalamin (vitamin B12) leading to a reduction of specificity of the assay. The problem could have been aggravated by a low pH in most assay systems which reduced the binding of vitamin B,2 by intrinsic factor but not its binding by R proteins.' Some doubt has been cast on this explanation by the failure of others to find any evidence of such cobalamin analogues in serum.23 It is also difficult to reconcile a loss of assay specificity attributable to R proteins with the observations of others that an assay using an R protein as a binder, rather than intrinsic factor, may give an excellent separation of patients with pernicious anaemia from normal.78 Despite this uncertainty, assay methods have been modified either by purifying intrinsic factor or by blocking R proteins (but not intrinsic factor) with cobinamide, or other vitamin B,2 analogues. The commercial kit which w'e have assessed is based on the latter principle. We found the sensitivity of the assay to deficiency of vitamin B,2 to be comparable to that of a microbiological assay using L leichmannii. Furthermore this kit was found to be capable of detecting low serum vitamin B,2 concentrations in four patients whose sera had given misleadingly normal values with two other commercial kits in which R proteins had not been blocked or removed. Since commercial kits have been modified by the purification of intrinsic factor, or by blocking of R proteins erroneously high B,2 values have been much less reported, and an im-provement of performance of Becton Dickinson kits in quality control surveys was noted following such kit modification.9 Our findings in four patients whose sera had been assayed in other laboratories using unmodified kits support the need for modification.
Erroneously low results with radioassays have also been reported in prototype commercial kits,'"1 this being attributed to high non-specific binding in the supematant, and inadequate removal of free vitamin BI2 by the absorbent. It is also theoretically possible for erroneously low assay results to be produced by contamination of the patient's serum or counting vials by radioactive isotopes. With the kit assessed we found the incidence of falsely low assay results to be acceptably low. It is not uncommon to find that elderly patients, vegetarians and post-gastrectomy patients have low concentrations of serum vitamin B,2 without other features of B12 deficiency. Low concentrations in such patients were found with the radioassay and must be regarded as valid results rather than indicating any lack of specificity of the assay. Since microbiological assays were not performed on all samples submitted, we cannot assess the frequency of falsely-low concentrations with a microbiological assay.
Because of the grave consequences of failure to recognise vitamin B12 deficiency, an assay with a significant number of falsely-normal concentrations is unacceptable. The competitive protein binding radioassay assessed in this paper is acceptable in this regard, and also as regards linearity, precision, and specificity. Nevertheless in interpreting patient data it should be remembered that any test is subject to random errors of various types, and if any laboratory result conflicts with clinical judgement then further assessment of the patient is essential.
